Citations

Showing 10 of 107850 citations.

Colony‐stimulating factor 1 receptor‐related disorder: Clinical variability of biallelic variants
Milanowski, Łukasz , Santos, Mara Lucia Schmitz Ferreira , Teive, Helio G., Fink, John K., Orthmann‐Murphy, Jennifer, Arnold, Kaley, Wszołek, Zbigniew K. , Wszolek, Z.K. , Milanowski, Łukasz M , Souza, Josiane , Teive, Hélio Afonso Ghizoni , Fink, John K. , Orthmann‐Murphy, Jennifer , Dulski, Jarosław , Group, CSF1R‐RD Study

Mayo Clinic

Developmental Medicine & Child Neurology | September 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/dmcn.70515 | PMID 42706750 Get It

Abstract Biallelic colony‐stimulating factor 1 receptor ( CSF1R ) variants are a major cause of early‐onset CSF1R ‐related disorder (CSF1R‐RD), although fewer than 30 cases have been reported and genotype–phenotype correlations remain unclear. The aim of this study was to characterize the clinical, radiological, and genetic features of patients with brain abnormalities, neurodegeneration, and dysosteosclerosis (BANDDOS). Six patients with biallelic CSF1R variants underwent detailed clinical, neurological, and magnetic resonance imaging evaluation. Three siblings with a homozygous p.Gly585Val variant showed marked phenotypic variability, ranging from severe childhood‐onset neurodegeneration to an asymptomatic presentation, all with white matter abnormalities. Three unrelated patients carried different biallelic CSF1R variants and presented with congenital skeletal abnormalities or early‐onset neurological disease of variable severity. These cases broaden the phenotypic spectrum of biallelic CSF1R‐RD and demonstrate that disease severity cannot be predicted solely by genotype, suggesting an important role for genetic or environmental modifiers.
Psychosocial Stressors and Psychiatric Morbidity Among Afghan Refugees Attending a Psychiatry Clinic in Islamabad, Pakistan: A Descriptive Cross-Sectional Study
Nadeem, Mahrukh , Khan, Ahmed Ali , Mansoor, Muhammad Hussain , Yousafzai, Abdul Wahab

Mayo Clinic

No container title available | September 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.09.03.26362105 Get It

ABSTRACT BACKGROUND War refugees are prone to psychiatric ailments due to multiple psychosocial stressors. Afghan refugees remain underrepresented in psychiatric studies. Therefore, a study exploring factors contributing to their mental health disorders is essential to guide rehabilitation efforts worldwide. METHODS This descriptive cross-sectional study evaluates the demographics, psychosocial stressors, psychiatric illnesses, and psychotropic drug use among Afghan refugees visiting the Psychiatry Outpatient Department (OPD) in Islamabad, Pakistan. Convenience sampling was employed on a sample population (n) of 75 participants. Data was collected via a structured questionnaire and analyzed using SPSS v21.0. Qualitative and quantitative variables were analyzed statistically. RESULTS Nearly 64%(n=48) of the participants were female. About 46.7%(n=35) of participants were uneducated, and 53.3%(n=40) were unemployed. 86.7%(n=65) of participants were married, while 2.7%(n=2) were divorced. 91%(n=61) of the married and divorced participants had an arranged marriage, 46.3%(n=31) had 5-8 children, and 67.2%(n=45) had experienced physical and/or emotional abuse. 74.7%(n=56) of the total participants reported a loss in the family, while 77.3%(n=58) had experienced trauma. 62.7%(n=47) had depression and associated psychotropic use, e.g., SSRIs (42.7%), TCAs (16%), and Benzodiazepines (13.3%). Alarmingly, 37.3%(n=28) reported a previous suicide attempt. CONCLUSION This study explores the psychosocial stressors faced by Afghan refugees in Pakistan, including displacement, abuse, trauma, and family/income loss. It emphasizes the importance of evidence-based psychiatric care, rehabilitative interventions, and culturally sensitive care to counter psychiatric morbidities and underscores the need for future research to improve the mental health of refugees globally.
Foam Cells Beyond the Intima: Adventitial Macrophage Lipid Loading in Transplant Arteriosclerosis
Lutgens, Esther , Monaco, Claudia , Lutgens, Esther , Monaco, Claudia

Mayo Clinic

Circulation | September 8, 2026 | Volume: 154 | Issue: 10 | Pages: 931-933

10.1161/circulationaha.126.081817 | PMID 42709917 Get It

Building trauma-informed physical therapists: a mixed-methods evaluation of a multimodal training module in hybrid DPT education
Parr, Rebecca E. , Richardson, Michael V., Anderson, Kristen, Anderson, Kristen

Mayo Clinic

Physiotherapy Theory and Practice | September 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-16

10.1080/09593985.2026.2730589 | PMID 42708499 Get It

Redefining Severe Aortic Stenosis in Symptomatic Patients: The Weakness of Using Simple Cutoffs
Carabello, Blasé A. , Nishimura, Rick A. , Carabello, Blase , Nishimura, Rick A

Mayo Clinic

Circulation | September 8, 2026 | Volume: 154 | Issue: 10 | Pages: 873-875

10.1161/circulationaha.126.081126 | PMID 42709915 Get It

Large Language Models for PVC Localization: Proof of Concept or Clinical Tool?
Siotis, Alexander , Kowlgi, Gurukripa N. , Deshmukh, Abhishek , Deshmukh, Abhishek J , Kowlgi, Narayan G

Mayo Clinic

Journal of Cardiovascular Electrophysiology | September 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/jce.70499 | PMID 42709933 Get It

Menopausal Hormone Therapy and Cardiovascular—Laying the Foundation for Future Trials
Castaneda, Regina, Faubion, Stephanie S., Castaneda, Regina , Faubion, Stephanie S.

Mayo Clinic

JAMA Internal Medicine | September 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1001/jamainternmed.2026.2877 | PMID 42709427 Get It

Follicular lymphoma and the microenvironment: potential targets and biomarkers
Yang, Zhi-Zhang, Ansell, Stephen M.

Mayo Clinic

Expert Review of Clinical Immunology | September 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-15

10.1080/1744666x.2026.2731956 | PMID 42708889 Get It

Electrochemical immunosensor-enabled liquid biopsy of extracellular vesicles for diagnosis of metabolic dysfunction-associated steatohepatitis
Nguyen, Thi Thanh Qui, Lee, Seonhwa , Mauer, Amy S. , Giron, Anthony, Cedillo‐Alcantar, Diana F. , Graham, Rondell, Allen, Alina, Revzin, Alexander, Choi, Daheui , Hoyos‐Vega, José M. de , Daniel, P. Vineeth , Eller, Michael J. , Stybayeva, Gulnaz , Lazaridis, Konstantinos , Malhi, Harmeet , Revzin, Alexander

Mayo Clinic

No container title available | September 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.09.02.26362088 Get It

Abstract Accurate, noninvasive biomarkers for diagnosis and longitudinal monitoring of metabolic dysfunction–associated steatohepatitis (MASH) remain an urgent unmet clinical need. Here, we describe an electrochemical immunoassay that involves capturing hepatic extracellular vesicles (EVs) on antibody-modified electrodes followed by detecting EV-borne biomarkers using redox active gold nanoparticles (AuNPs). The intensity of electrochemical redox signal represents a quantitative measure of biomarker abundance. Three MASH-associated biomarkers—S100A11, TNF-α, and TGF-β1—were analyzed on hepatic EVs to assess steatotic, inflammatory, and fibrotic states of the diseased liver. The electrochemical signals for individual biomarkers were added into a composite EV MASH score. Plasma samples from 28 patients with MASH, 22 healthy controls, and 27 patients with non-MASH liver disease were scored in this manner, revealing 100% accuracy in the training cohort and >90% accuracy in an independent validation cohort. Our electrochemical immunosensor represents a minimally invasive liquid liver biopsy, offering a promising alternative to solid liver biopsies for screening and monitoring of MASH. One Sentence Summary Circulating hepatic extracellular vesicles carry biomarkers of liver injury enabling accurate, minimally invasive MASH diagnosis in blood.
Maladaptive Piezo1 Mechanotransduction Drives Smooth Muscle Aging in the Gut
Joshi, Vikram , Seavey, Corey, Knutson, Kaitlyn, Sawant, Abhilash, Hamed, Yasmeen M F , D'Ambrosio, Mario, Laible, Emma, Sinnwell, Jason Paul, Liu, Yuanhang , Jin, Franco F, Thomas, C. T., Garramone, Gwyneth, Mazzone, Amelia Paul, Du, Peng , Grover, Madhusudan , Kashyap, Purna , Druliner, Brooke R. , Cipriani, Gianluca , Marshall, Kara L. , Farrugia, Gianrico, Joshi, Vikram , Seavey, Corey , Knutson, Kaitlyn R. , D’Ambrosio, Mario , Sinnwell, Jason P. , Garramone, Gwyneth K., Mazzone, Amelia , Bonfiglio, Ferdinando , D’Amato, Mauro , Avci, Recep , Linden, David R. , Bae, Yongho , Farrugia, Gianrico , Beyder, Arthur

Mayo Clinic

No container title available | September 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.09.02.748183 Get It

Age-related gastrointestinal dysfunction is common, but the mechanisms of aging-associated smooth muscle failure remain unclear. We show that aging in mice slows whole gut and colonic transit, increases regional stiffness, and reduces smooth muscle contractility. Inducible smooth muscle cell (SMC)– specific deletion of Piezo1 preserved youthful transit and force generation, whereas Piezo1 activation in young mice phenocopied aging-associated transit delay. Single-cell transcriptomics, RNA velocity, stiffness-controlled cell and tissue cultures, and pharmacologic studies revealed that Piezo1 couples increased stiffness to Ca 2+ –calcineurin–NFAT signaling, loss of contractile gene programs, leading to age- related contractile loss and contractile-to-synthetic SMC remodeling and gut wall stiffening. Human intestinal SMCs supported conservation of this pathway, and PIEZO1 gain-of-function carriers showed a trend toward delayed colonic transit. Thus, maladaptive SMC Piezo1 mechanotransduction is a targetable mechanism of aging-associated gut dysmotility. Aging alters organ structure, yet how these changes drive functional decline remains poorly defined. We show that progressive stiffening of the gut with age activates the mechanosensitive ion channel Piezo1 in smooth muscle cells, initiating a maladaptive response that impairs contractility and slows intestinal transit. On the other hand, deletion of smooth muscle Piezo1 prevents age-related gut dysmotility. These findings reveal that age-related physical shifts actively drive functional decline through mechanotransduction pathways. By identifying Piezo1 as a critical link between tissue mechanics and organ aging, this work provides a framework for understanding how mechanical cues contribute to age-related dysfunction in the gut and possibly other smooth muscle organs.